Skip to main content
Caplight Logo









Opyn

Opyn

Private
Wayne, PennsylvaniaHealthcare & Life Scienceshttps://www.opynhealth.com/

Last Round

Seed Round

Sep 3, 2026

Total Funding Raised

$72.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Opyn is a healthcare technology company that provides an AI-powered platform unifying benefits navigation, virtual care, price transparency, and provider intelligence to simplify healthcare management for plans and members.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, HR, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

benefits engagementhealthcare navigationAI virtual assistantbenefits administrationHR techAI agenthealthcare accessvertical SaaSemployee benefitsthird party administratorTPAbenefits platformgenerative AIhealthcare benefitsAI copilot

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Opyn Comparables

Compare Opyn with similar companies based on industry and business-model similarity.

Opyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medefy
81%
Healthee
81%
Nayya
77%

Opyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundSep 3, 2026
DebtApr 3, 2023
Series CApr 13, 2021
Series BMar 10, 2020
Series AOct 30, 2018

Key People

Founding team and executive leadership

Brent Matzelle

EVP, Chief Technology Officer (CTO)

Executive Team

Luis Rodriguez

Chief Operating Officer

Executive Team

Lou D.

CFO Sr. Vice President of Finance, Vice President, Finance

Executive Team

Ben Callaghan

Chief Product Officer

Executive Team

Opyn Investors

Notable investors and investment history

Opyn investors
InvestorRounds
Benjamin Franklin Technology PartnersSeries B, Series A
ARTIS VenturesSeries C
Phase 2 PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    $4.5M raised in Seed Round.

  • Aug 22, 2026

    Monthly visitors grew 247% MoM, reaching 1.7K.

Opyn Filings

Explore SEC and related filing metadata, where available.

Opyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Opyn's valuation, stock price, and market status.

Is Opyn a public or private company?

Opyn is a private company.

What is the current stock price of Opyn?

Opyn is a private company with no public stock price. No recent secondary market data is available.

How much is Opyn worth (valuation)?

Valuation information for Opyn is not publicly available.

Can I buy Opyn stock?

Opyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Opyn's last funding round?

Opyn's most recent funding round was Debt on April 3, 2023.

Who are the main investors in Opyn?

Key investors in Opyn include ARTIS Ventures.

Will Opyn IPO soon?

No public IPO plans have been announced for Opyn.

How can I track Opyn secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Opyn's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWayne, Pennsylvania
Employee Range23
Year Founded2015
Last FundingSep 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?